CD274 and B-cell chronic lymphocytic leukemia: PD-L1 expressed by CLL-cells can inhibit T-cell activation [41], suppress the secretion of effector cytokines by T-cells [65], enhance T-cell exhaustion, and impair the formation of immune synapses [40].